Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Meflynate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Meflynate XL 20mg capsules
0404000M0BNABAQ
|
Meflynate | Methylphenidate hydrochloride | Central Nervous System | 2,232 |
|
Meflynate XL 30mg capsules
0404000M0BNACAV
|
Meflynate | Methylphenidate hydrochloride | Central Nervous System | 1,990 |
|
Meflynate XL 10mg capsules
0404000M0BNAAAU
|
Meflynate | Methylphenidate hydrochloride | Central Nervous System | 1,628 |
|
Meflynate XL 40mg capsules
0404000M0BNADAW
|
Meflynate | Methylphenidate hydrochloride | Central Nervous System | 1,240 |
|
Meflynate XL 60mg capsules
0404000M0BNAEBA
|
Meflynate | Methylphenidate hydrochloride | Central Nervous System | 422 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.